Treatment and Patient Selection for Patients with Metastatic Castration-resistant Prostate After Progression on Docetaxel and Abiraterone/Enzalutamide: When to Play Your CARD and When to Do Your PARP.
Treatment and Patient Selection for Patients with Metastatic Castration-resistant Prostate After Progression on Docetaxel and Abiraterone/Enzalutamide: When to Play Your CARD and When to Do Your PARP.
复制标题
多西他赛和阿比特龙/恩杂鲁胺进展后转移性去势抵抗性前列腺患者的治疗和患者选择：何时进行 CARD 以及何时进行 PARP。
作者：
A. Robinson;J. Izard;F. Vera
DOI：
10.1056/nejmoa1405095
发表时间：
2014-07-31
期刊：
The New England journal of medicine
影响因子：
--
作者：
Beer TM;Armstrong AJ;Rathkopf DE;Loriot Y;Sternberg CN;Higano CS;Iversen P;Bhattacharya S;Carles J;Chowdhury S;Davis ID;de Bono JS;Evans CP;Fizazi K;Joshua AM;Kim CS;Kimura G;Mainwaring P;Mansbach H;Miller K;Noonberg SB;Perabo F;Phung D;Saad F;Scher HI;Taplin ME;Venner PM;Tombal B;PREVAIL Investigators
通讯作者：
PREVAIL Investigators